Development of ligand modified erythrocyte coated polydopamine nanomedicine to codeliver chemotherapeutic agent and oxygen for chemo-photothermal synergistic cancer therapy
- 2 September 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 626, 122156
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Science Technology and Innovation Commission
- Guangzhou Municipal Science and Technology Program key projects (201604046022, 201802030002)
- Department of Education of Guangdong Province (2022ZDZX2034)
This publication has 45 references indexed in Scilit:
- Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal TherapyACS Nano, 2016
- Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicinJournal of Controlled Release, 2016
- Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor SuppressionMolecular Pharmaceutics, 2016
- Proteome analysis of the triton-insoluble erythrocyte membrane skeletonJournal of Proteomics, 2015
- Delivery of Drugs Bound to erythrocytes: New Avenues for an Old Intravascular CarrierTherapeutic Delivery, 2015
- Nano-Engineered Erythrocyte Ghosts as Inhalational Carriers for Delivery of Fasudil: Preparation and CharacterizationPharmaceutical Research, 2014
- Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug DeliveryChemistry of Materials, 2013
- Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agentsNature Materials, 2011
- Mussel-Inspired Surface Chemistry for Multifunctional CoatingsScience, 2007
- Enzyme Loading of ErythrocytesProceedings of the National Academy of Sciences, 1973